Background: Healthy skin with integrity is essential for maintaining one’s physical, mental, and social wellbeing. Vitiligo, a chronic autoimmune dermatosis characterized by asymptomatic, achromic macules, affects the integrity of the skin. Methodology: This was a descriptive, cross-sectional study conducted from March to June 2019 in six public hospitals in the city of Ouagadougou, Burkina Faso. The patients included in the study were followed in the dermatology departments of these structures for vitiligo, aged at least eighteen years and consenting. The Dermatology Life Quality Index (DLQI) and the vitiligo-specific health-related quality of life scale (VitiQoL) were employed to measure QoL (quality of life). Results: A total of fifty patients agreed to participate in the study. The mean age was 40.56 years, ranging from 18 to 79 years. There were as many females as males (25), and 23 married patients out of the fifty. The majority of the patients (43/50) resided in urban areas. Twenty-six patients had at least secondary education and eighteen patients worked in the informal sector. The average duration of vitiligo progression was 10.56 years, ranging from three months to 49 years. The evolution of vitiligo was stationary for 17/50 patients. The lesions were mainly located on the head and neck. The average body surface area (BSA) affected was 12.04%, ranging from 1% to 82%. The treatment was mainly local and general corticosteroid therapy. The evaluation of the patients’ quality of life (QoL) by the DLQI (Dermatology Life Quality Index) yielded a mean score of 5.44/30. Vitiligo had a small effect on the QoL of eighteen patients and a moderate effect on sixteen patients. VitiQoL assessment yielded a mean total score of 32.32/96 and stigma had the highest score of 18.04/36. The patients’ QoL was influenced by age and body surface area affected by vitiligo. Restriction of participation in activities and changes in the patient’s behavior were significantly correlated with the duration of vitiligo progression, followed by stigma, which was related to vitiligo progression. Conclusion: The alteration of the QoL of the patients with vitiligo was low to moderate. This alteration was related to the stigmatization by one’s environment.
Background: Psoriasis is a chronic, displaying inflammatory dermatosis. The evaluation of the psychosocial impact of chronic dermatoses on the quality of life of patients may help to orientate the objectives of management in order to improve their daily life, hence the interest of our study with the objective to evaluate the impact of psoriasis on the quality of life of patients followed in the dermatology, venereology, and rheumatology departments of the city of Ouagadougou, Burkina Faso. Patients and Method: This was a descriptive, cross-sectional study that took place from March 1 to June 28, 2019, in six public hospitals in the city of Ouagadougou. The Dermatology Life Quality Index (DLQI) and Psoriasis Disability Index (PDI) were the quality of life tools employed for this study. Results: Forty-eight (48) patients with psoriasis met the inclusion criteria. The mean age of the patients was 46.20 years, ranging from 22 to 79 years. There were 18 females and 30 males, with a sex ratio of 1.6. The measurement of the patients’ QoL by the DLQI reported a mean score of 9.14 out of 30. There was a low impact of the disease on the QoL for seventeen patients. The evaluation of the QOL with the PDI noted an alteration of daily activities (3.95/15) and alteration of the patients’ psychosocial relationships (2.66/18). The analysis of the QoL according to sociodemographic and clinical variables noted an alteration significantly related to age, level of education, and severity of the disease. An alteration in professional relationships was significant in female patients. An alteration in the different dimensions of the QoL was more significant in patients with a low level of education. The duration of the disease seemed to have no impact on the patients’ quality of life. Daily activities were significantly altered for patients with a PASI between 7 and 10. The DLQI did not correlate with disease severity (PASI) (r = 0.228; p = 0.120), unlike the PDI (r = 0.371; p = 0.009). Conclusion: The QoL of psoriatic patients in Ouagadougou seemed to be slightly altered. This alteration was more significant for females. Professional relationships were altered for young subjects while daily activities were altered for those older.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.